PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 8,000,000 SHARES OF COMMON STOCK JUNE 22, 2005Common Stock Purchase Agreement • June 24th, 2005 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 24th, 2005 Company Industry JurisdictionThis Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of June 22, 2005 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).